Hudson Institute Cell Therapies

Hudson Institute Cell Therapies (HICT) is a specialized cell therapy manufacturing facility located within the Hudson Institute of Medical Research in Melbourne, Australia. As a Therapeutic Goods Administration (TGA) licensed facility, HICT provides essential contract development and manufacturing organization (CDMO) services for clinical-grade cellular therapies. The facility bridges the gap between laboratory research and clinical application, supporting both academic and commercial partners in the production of mesenchymal stem cells, dendritic cells, and other advanced cellular products. HICT is a key player in the Australian biotech landscape, particularly in the fields of regenerative medicine, oncology, and inflammation. Their state-of-the-art cleanrooms are designed to meet international regulatory standards for early-phase human clinical trials.